4//SEC Filing
Toledano Miranda Jayne 4
Accession 0001178913-25-002414
CIK 0001638097other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 4:37 PM ET
Size
10.1 KB
Accession
0001178913-25-002414
Insider Transaction Report
Form 4
Entera Bio Ltd.ENTX
Toledano Miranda Jayne
DirectorChief Executive Officer
Transactions
- Award
Ordinary Shares, par value NIS 0.0000769 per share
2025-07-16+43,860→ 415,575 total - Award
Ordinary Shares, par value NIS 0.0000769 per share
2025-07-16+136,842→ 371,715 total - Award
Stock Option (Right to Buy)
2025-07-16+500,000→ 500,000 totalExercise: $2.28Exp: 2035-04-28→ Ordinary Shares, par value NIS 0.0000769 per share (500,000 underlying)
Footnotes (3)
- [F1]Represent a grant of stock-settled restricted stock units. This grant of stock-settled restricted stock units was approved by the Board of Directors (the "Board") of Entera Bio Ltd. (the "Company") on April 28, 2025, subject to approval by the Company's shareholders, which was obtained on July 16, 2025. This grant was awarded to the Reporting Person in lieu of the Reporting Person's 2024 annual cash bonus. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 28, 2025.
- [F2]Represent a grant of stock-settled restricted stock units. This grant of stock-settled restricted stock units was approved by the Board on April 28, 2025, subject to approval by the Company's shareholders, which was obtained on July 16, 2025. This grant was awarded to the Reporting Person in lieu of $100,000 the Reporting Person is entitled to under the Reporting Person's base salary for 2025. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 1, 2025.
- [F3]This grant of options was approved by the Board on April 28, 2025, subject to approval by the Company's shareholders, which was obtained on July 16, 2025. The options vest over a three-year period that commenced on April 28, 2025, with a third of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining two-year period.
Documents
Issuer
Entera Bio Ltd.
CIK 0001638097
Entity typeother
Related Parties
1- filerCIK 0001686530
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 4:37 PM ET
- Size
- 10.1 KB